Mesoblast (MESO) Exchange Rate Effect (2016 - 2023)
Mesoblast (MESO) posted quarterly Exchange Rate Effect of $24000.0 for Q2 2023, up 115.38% year-on-year from $11142.9 in Q2 2022, and up 142.86% on a QoQ basis from -$56000.0 in Q1 2023.
Mesoblast (MESO) Exchange Rate Effect (2016 - 2023) Analysis & Trends
Mesoblast (MESO) has reported Exchange Rate Effect for 8 consecutive years, with $24000.0 the latest figure, recorded in Q2 2023.
- Quarterly Exchange Rate Effect rose 115.38% year-over-year to $24000.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was -$168000.0 (up 69.45% YoY) and the FY2025 annual result came in at $1.1 million, up 2080.0% from the prior year.
- Exchange Rate Effect improved to $24000.0 in Q2 2023 per MESO's latest filing, from -$56000.0 in the prior quarter.
- Over the last five years, Exchange Rate Effect for MESO reached as high as $1.8 million in Q2 2020 and fell as low as -$753000.0 in Q3 2022.
- A 5-year average of $122611.1 and a median of $3000.0 in 2021 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2020 — Exchange Rate Effect jumped 4352.38% — and 2022, when it plunged 7700.0%.
- Year by year, Exchange Rate Effect stood at $371000.0 in 2019, then jumped by 206.2% to $1.1 million in 2020, then sank by 93.4% to $75000.0 in 2021, then surged by 722.67% to $617000.0 in 2022, then slumped by 96.11% to $24000.0 in 2023.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $24000.0, -$56000.0, and $617000.0 for Q2 2023, Q1 2023, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 24,000.00 |
| Jun 30, 2023 | 24,000.00 |
| Mar 31, 2023 | -56,000.00 |
| Mar 31, 2023 | -56,000.00 |
| Dec 31, 2022 | 617,000.00 |
| Dec 31, 2022 | 617,000.00 |
| Sep 30, 2022 | -753,000.00 |
| Sep 30, 2022 | -753,000.00 |
| Jun 30, 2022 | -156,000.00 |
| Jun 30, 2022 | -156,000.00 |
| Mar 31, 2022 | 8,000.00 |
| Mar 31, 2022 | 8,000.00 |
| Dec 31, 2021 | 75,000.00 |
| Dec 31, 2021 | 75,000.00 |
| Sep 30, 2021 | -477,000.00 |
| Sep 30, 2021 | -477,000.00 |
| Jun 30, 2021 | -2,000.00 |
| Jun 30, 2021 | -2,000.00 |
| Mar 31, 2021 | -220,000.00 |
| Mar 31, 2021 | -220,000.00 |